Recent Posts
- ReForm Biologics and MilliporeSigma Announce a Licensing Agreement for Excipient Development and Commercialization
- ReForm Biologics Announces Issuance of U.S. Patent on Additional Excipients for Therapeutic Protein Formulations
- Former Panasonic North America CEO and New VP Boost Imprint Energy Business Team
- Imprint Energy Expands Access to Safe, Flexible Batteries for High-Volume IoT Applications
- ReForm Biologics Announces Two New Technology Presentations at Bioprocessing Summit 2019